Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region
Clinical trial NCT04468165 · COMPLETED
Trial details
- NCT number
- NCT04468165
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-23
- Primary completion
- 2023-07-20
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.